INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC
Position in ARWR — Arrowhead Pharmaceuticals, Inc.
CIK 1818604
ORLANDO, FL
Position in ARWR
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$213,995
-$1,227,888 QoQ
Shares Held
3,413
-95.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
5 quarters on record
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC holds $2,217,457 across 52 Biotechnology names. ARWR ranks #2 (9.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
881 | $680,695 | |
| 2 | ARWR |
Arrowhead Pharmaceuticals, Inc.
This page
|
3,413 | $213,995 | |
| 3 | VKTX |
Viking Therapeutics, Inc.
|
5,927 | $192,864 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
426 | $190,226 | |
| 5 | INSM |
INSMED Inc
|
699 | $114,300 | |
| 6 | SRPT |
Sarepta Therapeutics, Inc.
|
4,464 | $97,136 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,221 | $91,684 | |
| 8 | MRNA |
Moderna, Inc.
|
1,783 | $90,576 |
All Filings in ARWR
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $213,995 | 3,413 | Shares | Sole | 2026-05-01 | |
| 2024-09-30 | $1,441,883 | 74,439 | Shares | Sole | 2024-10-22 | |
| 2022-12-31 | $4,041,438 | 99,641 | Shares | Sole | 2023-01-30 | |
| 2021-03-31 | $74,466 | 1,123 | Shares | Sole | 2021-04-19 | |
| 2020-12-31 | $86,167 | 1,123 | Shares | Sole | 2021-04-19 | |
| No filing history on record for this holder in this stock. | ||||||